{"id":"W4400382953","doi":"10.14740/wjon1853","title":"Opportunities and Challenges in the Development of Antibody-Drug Conjugate for Triple-Negative Breast Cancer: The Diverse Choices and Changing Needs","year":2024,"lang":"en","type":"article","venue":"World Journal of Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Yunnan Provincial Science and Technology Department; Kunming Medical University","keywords":"Medicine; Triple-negative breast cancer; Conjugate; Antibody-drug conjugate; Drug; Breast cancer; Antibody; Drug development; Oncology; Cancer; Monoclonal antibody; Immunology; Internal medicine; Pharmacology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004270221,0.0005562418,0.001017941,0.0007987117,0.0005078928,0.002345114,0.0009746454,0.001954892,0.004073055],"category_scores_gemma":[0.002676495,0.0003617725,0.0007376714,0.0008152938,0.001103777,0.005967936,0.001410019,0.003248637,0.001672297],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006562963,"about_ca_system_score_gemma":0.002079094,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006068396,"about_ca_topic_score_gemma":0.001501565,"domain_scores_codex":[0.9988172,0.0003479836,0.0001192556,0.0001809079,0.0003806357,0.0001539363],"domain_scores_gemma":[0.9982065,0.0007945074,0.0001982208,0.00006300629,0.0005118057,0.0002259725],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003300381,0.000270319,0.001888533,0.01033944,0.00009273687,0.00112666,0.0008286372,0.002344464,0.02230583,0.02982682,0.03403303,0.8966134],"study_design_scores_gemma":[0.00007655676,0.001319244,0.001310955,0.002601665,0.0001603088,0.004255089,0.001936629,0.002875604,0.01366191,0.02980635,0.9418656,0.0001300947],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.007522307,0.9608081,0.006687133,0.01920515,0.000809514,0.00003786187,0.00009426466,0.00007628684,0.004759368],"genre_scores_gemma":[0.03314526,0.942596,0.01359733,0.005596356,0.0011773,0.00007193302,0.000243324,0.00004165912,0.003530816],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004270221,"threshold_uncertainty_score":0.02258337,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2000868260793801,"score_gpt":0.4285066110945388,"score_spread":0.2284197850151587,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}